Physician profile
Richard Selser
NPI 1194778126
$816.91
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $134 · 2021: $153 · 2022: $81.18.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $390.39 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $95.46 | 2019-2020 | |
| Ivantis, INC | $71.42 | 2019 | |
| Allergan, INC. | $54.56 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $39.84 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $39.08 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $31.26 | 2019 | |
| Glaukos Corporation | $18.00 | 2022 | |
| Omeros Corporation | $17.39 | 2021 | |
| Horizon Therapeutics Plc | $16.60 | 2022 | |
| Aerie Pharmaceuticals, INC. | $16.06 | 2020 | |
| Dompe US, INC. | $14.87 | 2019 | |
| Shire North American Group INC | $11.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Selser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.